Ionis Pharmaceuticals Other Assets

Ionis Pharmaceuticals posts a other assets of $0 as of June 2026. That compares with $420M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ionis Pharmaceuticals's other assets was $420M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Assets is one piece of Ionis Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IONS's other assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Ionis Pharmaceuticals's other metric pages and overview cover the third.

Judging Ionis Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other assets easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.